Zai Lab

IPO

Zai Lab is a biotech company in Shanghai, China, founded in 2014. It has raised $130.0M across 2 rounds, most recently a $100.0M Series B in June 2016.

Headquarters
Shanghai
Employees
1001–5000
Founded
2014
Business Model
B2B
Total Funding
$130.0M
Last Round
$100.0M Series BJun 2016
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Zai Lab is a patient-focused, commercial-stage global biopharmaceutical company based in China and the United States. Founded in 2014 by Dr. Samantha Du, it discovers, develops, and commercializes best-in-class and first-in-class therapies for oncology, immunology, neuroscience, and infectious disease. The company combines scientific innovation with operational scale across headquarters in Cambridge, Massachusetts, and Shanghai, plus teams in Greater China, the U.S., and Europe. Its pipeline includes zocilurtatug pelitecan, a DLL3-targeted antibody-drug conjugate in clinical trials for small cell lung cancer, along with other global programs such as ZL-1503 for atopic dermatitis and ZL-6201 for solid tumors.

Summary

It lists 1001–5000 employees. It has raised $130.0M in total across 2 rounds, most recently a $100.0M Series B round in Jun 2016.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPONov 2017

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zai Lab on Indexed.vc
<a href="https://indexed.vc/companies/zai-lab"><img src="https://indexed.vc/api/badge/company/zai-lab" alt="Zai Lab on Indexed.vc" width="260" height="76" /></a>